Nomenclature of drug-resistant tuberculosis

The Lancet Infectious Diseases

Volumn 13, Issue 11, 2013, Pages 917-

  Udwadia, Zarir F ^a   Amale, Rohit A ^a   Ajbani, Kanchan K ^a   Rodrigues, Camilla S ^a  

^a P D HINDUJA NATIONAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; CAPREOMYCIN; ETHIONAMIDE; KANAMYCIN; MOXIFLOXACIN; OFLOXACIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; DRUG RESISTANT TUBERCULOSIS; HUMAN; LETTER; NOMENCLATURE; PRIORITY JOURNAL;

ANTITUBERCULAR AGENTS; HUMANS; MYCOBACTERIUM TUBERCULOSIS; TERMINOLOGY AS TOPIC; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84886929656     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(13)70291-3     Document Type: Letter

References (3)

1. Sullivan T, Ben Amor Y What's in name? The future of drug-resistant tuberculosis classification. Lancet Infect Dis 2013, 13:373-376.
2. Udwadia ZF, Amale RA, Ajbani KK, Rodrigues C Totally drug-resistant tuberculosis in India. Clin Infect Dis 2012, 54:579-581.
3. Cioran Emil A Short History of Decay 1949, Gallimard, Paris.